[1] Hilkens NA, Casolla B, Leung TW, et al.Stroke. Lancet. 2024;403(10446):2820-2836.
[2] Amarenco P, Lavallée PC, Labreuche J, et al. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke[J]. N Engl J Med, 2016, 374(16): 1533-42.
[3] 侯宇婷, 李通. 基于快速CYP2C19基因检测的急性基底动脉闭塞患者双联抗血小板治疗1例报道[J]. 中国卒中杂志, 2024, 19(10): 1125-30.
[4] Gao Y, Chen W, Pan Y, et al.Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke. N Engl [J] Med. 2023;389(26):2413-2424.
[5] 王嘉晶, 况杰, 涂江龙, 等. 氯吡格雷联合阿司匹林精准用药与脑卒中患者短期预后的关系[J]. 实用医学杂志, 2021, 37(13): 1737-41.
[6] Jung YH, Song TJ, Kim J, et al.Cytochrome P450 2C19 Genotypes and Clopidogrel in Patients With Ischemic Stroke: A Nonrandomized Clinical Trial[J]. JAMA Netw Open, 2025,8(4):e250398-411.
[7] Price MJ, Murray SS, Angiolillo DJ, et al. Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study[J]. J Am Coll Cardiol, 2012, 59(22): 1928-37.
[8] Lee CR, Luzum JA, Sangkuhl K, et al.Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update[J]. Clin Pharmacol Ther, 2022,112(5):959-967.
[9] Shuldiner AR, O'connell JR, Bliden KP, et al. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy[J]. Jama, 2009, 302(8): 849-57.
[10] Han M, Jia W, Wu Y, et al. Short-term efficacy and safety of personalized antiplatelet therapy for patients with acute ischaemic stroke or transient ischaemic attack: A randomized clinical trial[J]. Br J Clin Pharmacol, 2023, 89(9): 2813-24.
[11] Wang Y, Meng X, Wang A, et al. Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA[J]. N Engl J Med, 2021, 385(27): 2520-30.
[12] 庄源, 刘敦花. 黑龙江地区老年脑梗死患者CYP2C19基因多态性对氯吡格雷疗效的影响[J]. 中国卫生标准管理, 2024, 15(14): 118-21.
[13] 曾媛媛, 朱其凤, 张永全. 缺血性脑卒中与相关信号通路的关系及中医药调控的研究进展[J]. 中国实验方剂学杂志, 2024, 30(20): 252-63.
[14] 吴松, 任彬彬, 马素娜, 等. MSCs及其外泌体治疗缺血性脑卒中的作用机制[J]. 中国老年学杂志, 2025, 45(4): 1007-13.
[15] Khasawneh LQ, Alsafar H, Alblooshi H, et al.The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati population[J].Hum Genomics, 2024, 18(1):2-14. |
